Literature DB >> 1733637

Hyper-response of serum IgG1 to Staphylococcus aureus peptidoglycan in patients with hyper-IgE syndrome.

A Ishizaka1, K Kojima, Y Sakiyama, S Matsumoto, K Kuwajima, Y Wagatsuma, R Shibata, K Joh.   

Abstract

The hyper-IgE (HIE) syndrome is characterized by high IgE serum levels, chronic dermatitis and recurrent infections. To determine whether an impairment of the antibody response to Staphylococcus aureus contributes to infections in this syndrome we measured total serum IgG subclass, specific IgG1 and IgG2 levels against peptidoglycan (PG), the immunodominant cell wall component of S. aureus and serum opsonic activity to PG. Of the 14 patients with HIE syndrome, nine had increased level of serum IgG1 and six had IgG2 subclass deficiency. In regard to specific response of IgG1 and IgG2 antibodies to PG, patients were divided into five groups related to ages and compared with 10 control subjects for each age cohort. Patients with HIE syndrome had significant high levels of serum-specific IgG1 to PG and significant decreased levels of serum-specific IgG2 to PG in all five groups. Additionally, serum opsonic activity in patients was significantly higher than that in normal control subjects. It is concluded that IgG2 deficiency or poor IgG2 antibody response to S. aureus is not the explanation of the abnormal susceptibility to S. aureus infections of HIE patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733637      PMCID: PMC1554217          DOI: 10.1111/j.1365-2249.1992.tb06412.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.

Authors:  R L Berkow; D Wang; J W Larrick; R W Dodson; T H Howard
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

2.  Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes.

Authors:  A A te Velde; R J Huijbens; K Heije; J E de Vries; C G Figdor
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

3.  Development of hypogammaglobulinaemia in a patient with common variable immunodeficiency.

Authors:  A Ishizaka; M Nakanishi; S Yamada; Y Sakiyama; S Matsumoto
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

4.  Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome.

Authors:  G Del Prete; A Tiri; E Maggi; M De Carli; D Macchia; P Parronchi; M E Rossi; M C Pietrogrande; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

5.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis.

Authors:  R Paganelli; E Scala; M R Capobianchi; E Fanales-Belasio; G D'Offizi; M Fiorilli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

7.  Effect of recombinant human interleukin 4 on spontaneous in vitro human IgE synthesis.

Authors:  X D Yang; A L De Weck; B M Stadler
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 8.  Hyper immunoglobulin E syndrome.

Authors:  R S Geha; D Y Leung
Journal:  Immunodefic Rev       Date:  1989

9.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Y Bonnefoy; H Spits; T Yokota; N Arai; K Arai; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.

Authors:  R Peleman; J Wu; C Fargeas; G Delespesse
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  1 in total

1.  Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy.

Authors:  Udo Lorenz; Birgit Lorenz; Tim Schmitter; Karin Streker; Christian Erck; Jürgen Wehland; Joachim Nickel; Bastian Zimmermann; Knut Ohlsen
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.